PALMETTO PARTNERS, LTD. purchased 7.7% of their position (150K shares) of XERIS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $2.25M — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+930.38K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+581.99K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+447.69K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+150K
Price / share
$15.00
Trade value
$2.25M
% of position
Net shares
+2.11M
Net value
$2.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2018 | C · Conversion | +930.38K | — | — | New position | 0.00 | 930.38K |
| Common Stock Direct | 6/25/2018 | C · Conversion | +581.99K | — | — | 62.6% | 930.38K | 1.51M |
| Common Stock Direct | 6/25/2018 | C · Conversion | +447.69K | — | — | 29.6% | 1.51M | 1.96M |
| Common Stock Direct | 6/25/2018 | P · Purchase | +150K | $15.00 | $2.25M | 7.7% | 1.96M | 2.11M |
| Total | +2.11M | $2.25M | ||||||
Series A Preferred Stock
Common Stock
930.38K shares
Shares
−1.66M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
581.99K shares
Shares
−1.04M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
447.69K shares
Shares
−797.38K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock930.38K shares | 6/25/2018 | C · Conversion | −1.66M | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock581.99K shares | 6/25/2018 | C · Conversion | −1.04M | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock447.69K shares | 6/25/2018 | C · Conversion | −797.38K | — | 0.00 |